The total number of records retrieved from this search are 19. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1712	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1713	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1714	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1715	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1716	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1717	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1718	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1719	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1720	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1721	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1722	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1723	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1724	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1725	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1726	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineBJ-1	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant cell death after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_4113	Virus nameAdenovirus	Virus strainAd-CCL20-CD40L	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of CCL20 and CD40L gene near by TERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomevirus expressing CCL20 chemokine gene	Source of cell lineATCC	Origin of cell lineHuman fibroblast cell line BJ	Cell lineBJ	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result95% cell survival after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26208317
IDOV_4117	Virus nameAdenovirus	Virus strainAd-CCL20-CD40L	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of CCL20 and CD40L gene near by TERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomevirus expressing CCL20 chemokine gene	Source of cell lineATCC	Origin of cell lineHuman fibroblast cell line	Cell lineBJ	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result95% cell survival after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26208317
IDOV_4121	Virus nameAdenovirus	Virus strainAd-CCL20-CD40L	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of CCL20 and CD40L gene near by TERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomevirus expressing CCL20 chemokine gene	Source of cell lineATCC	Origin of cell lineHuman fibroblast cell line	Cell lineBJ	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26208317
IDOV_4125	Virus nameAdenovirus	Virus strainAd-CCL20-CD40L	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of CCL20 and CD40L gene near by TERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomevirus expressing CCL20 chemokine gene	Source of cell lineATCC	Origin of cell lineHuman fibroblast cell line	Cell lineBJ	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result95% cell survival after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26208317